Innovent Biologics NDA for IBI311 in thyroid eye disease treatment gets priority review in China

Pallavi Madhiraju- May 21, 2024 0

Innovent Biologics, Inc. (HKEX: 01801), a leading biopharmaceutical company, announced that its New Drug Application (NDA) for IBI311, a pioneering treatment for Thyroid Eye Disease ... Read More